Novartis to push for diabetes prevention indication with Diovan
18 March 2010
Asher Mullard
Despite only meeting one co-primary endpoint in the Phase III NAVIGATOR trial of Diovan (valsartan) in patients with impaired glucose tolerance (IGT), Novartis believes that its antihypertensive might be approvable for the prevention of diabetes in this population. Data presented at the American...
Please Login to read the full article.
18 March 2010
Asher Mullard
Please Login to read the full article.
RELATED CONTENT
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
